We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

168 hedge funds and large institutions have $1.61B invested in NxStage Medical Inc. in 2017 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,040% more call options, than puts

Call options by funds: $28.2M | Put options by funds: $2.47M

11% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 55

3% more funds holding

Funds holding: 163 → 168 (+5)

4% more capital invested

Capital invested by funds: $1.55B → $1.61B (+$66.3M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

24% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 51

Holders
168
Holders Change
+5
Holders Change %
+3.07%
% of All Funds
4.19%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
61
Increased
39
Reduced
51
Closed
55
Calls
$28.2M
Puts
$2.47M
Net Calls
+$25.7M
Net Calls Change
+$23.7M

Top Buyers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
+$106M
2
MF
Magnetar Financial
Illinois
+$82.1M
3
AA
AQR Arbitrage
Connecticut
+$78.4M
4
Deutsche Bank
Deutsche Bank
Germany
+$57.7M
5
JP Morgan Chase
JP Morgan Chase
New York
+$49.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$249M
2
EAM
Eagle Asset Management
Florida
-$64.5M
3
OIM
Oracle Investment Management
Connecticut
-$60.7M
4
DM
Deerfield Management
New York
-$60.1M
5
William Blair Investment Management
William Blair Investment Management
Illinois
-$49.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCIM
101
Meadow Creek Investment Management
Georgia
$1.13M -$136K -5,100 -11%
SG Americas Securities
102
SG Americas Securities
New York
$1.12M +$1.08M +40,499 New
BCM
103
Bayesian Capital Management
New York
$1.07M +$1.03M +38,704 New
UBS AM
104
UBS AM
Illinois
$1.06M +$118K +4,417 +13%
Principal Financial Group
105
Principal Financial Group
Iowa
$1.03M -$35.7K -1,339 -3%
WAM
106
Wolverine Asset Management
Illinois
$1.03M +$992K +37,200 New
NFA
107
Nationwide Fund Advisors
Ohio
$963K -$5.18M -194,071 -85%
EP
108
Elkfork Partners
Oregon
$930K -$112K -4,200 -11%
PAMP
109
Polar Asset Management Partners
Ontario, Canada
$897K +$867K +32,500 New
Legal & General Group
110
Legal & General Group
United Kingdom
$888K +$182K +6,843 +27%
DI
111
DUMAC Inc
North Carolina
$836K +$808K +30,300 New
TI
112
Telemetry Investments
New York
$828K +$800K +30,000 New
VOYA Investment Management
113
VOYA Investment Management
Georgia
$815K – – –
BCA
114
Burren Capital Advisors
Gibraltar
$806K +$779K +29,200 New
YCM
115
Yakira Capital Management
Connecticut
$737K +$713K +26,721 New
GHCM
116
Glen Harbor Capital Management
California
$730K -$88K -3,300 -11%
Simplex Trading
117
Simplex Trading
Illinois
$670K +$421K +15,793 +185%
GI
118
GAMCO Investors
Connecticut
$611K +$591K +22,153 New
Citadel Advisors
119
Citadel Advisors
Florida
$605K -$4.35M -163,236 -88%
AC
120
Athos Capital
Hong Kong
$579K +$559K +20,970 New
KAM
121
Kassirer Asset Management
Ontario, Canada
$552K +$533K +20,000 New
NA
122
Neuburgh Advisers
California
$531K -$64K -2,400 -11%
BHCM
123
Brevan Howard Capital Management
Jersey
$470K +$454K +17,016 New
SEC
124
Seven Eight Capital
New York
$469K +$453K +17,000 New
Hudson Bay Capital Management
125
Hudson Bay Capital Management
Connecticut
$403K +$389K +14,600 New
3 4
5
6 7

NXTM Hedge Fund Activity: Q3 2017 in Review

168 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2017, worth a combined $1.61B — up 4.3% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new NXTM positions and 55 closed out — a net gain of 6 holders — while 39 added to existing stakes and 51 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $106M. The largest seller was Fidelity Investments, cutting an estimated $249M.

  • 168 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2017, up from 163 in Q2 2017.
  • Funds reported $1.61B of NxStage Medical Inc. stock for Q3 2017, up 4.3% quarter-over-quarter.
  • 61 funds opened new NxStage Medical Inc. positions in Q3 2017 and 55 closed out, a net change of +6 holders.
  • The largest NxStage Medical Inc. buyer in Q3 2017 was Alpine Associates Management, an estimated $106M added.
  • The largest NxStage Medical Inc. seller in Q3 2017 was Fidelity Investments, an estimated $249M sold.

Based on aggregated 13F filings for Q3 2017.